バージニアにおける膵臓がんの臨床試験
バージニア内の拠点で、膵臓がんに関する40件の研究が参加者を募集しています。
バージニア内の都市
公式研究テキスト（英語）
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Blue Ridge Cancer Care, Blacksburg
- Virginia Cancer Specialists, Fairfax
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- NEXT Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07529808A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07127874A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- NEXT Oncology Virginia, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
- Virginia Cancer Specialists, Fairfax
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07252232Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NEXT Oncology Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- UVA Emily Couric Cancer Center, Charlottesville
- Inova Schar Cancer Institute Clinical Trials, Fairfax
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07409272Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Virginia Cancer Specialists, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Investigative Site US057, Fairfax
- Investigative Site US065, Fairfax
- Investigative Site US064, Salem
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07522073A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Next Oncology Virginia Cancer Specialist, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07629960Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- NEXT - Virginia, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07349537A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- NEXT Oncology, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06440005Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
- Inova Alexandria Hospital, Alexandria
- University of Virginia Cancer Center, Charlottesville
- Inova Schar Cancer Institute, Fairfax
- 他7件
被験者募集中観察研究
50歳〜75歳 · 全性別 · 2026/09/04更新 · NCT04239573A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- UVA Health, Charlottesville
- Virginia Cancer Specialists, Fairfax
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07644559The Vanguard Study: Testing a New Way to Screen for Cancer
- Sentara Martha Jefferson Hospital, Charlottesville
- Inova Schar Cancer Institute, Fairfax
- Inova Fair Oaks Hospital, Fairfax
- 他5件
被験者募集中健康なボランティア歓迎
45歳〜75歳 · 全性別 · 2026/09/02更新 · NCT06995898Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Virginia Cancer Specialists, PC, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05245500Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- VCU Massey Comprehensive Cancer Center, Richmond
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/01更新 · NCT04172532Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Inova Alexandria Hospital, Alexandria
- Inova Schar Cancer Institute, Fairfax
- Inova Fair Oaks Hospital, Fairfax
- 他6件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/25更新 · NCT06958328A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- NEXT Virginia, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/13更新 · NCT07066657Pancreatic Cancer Early Detection Consortium
- University of Virginia, Charlottesville
- Inova Schar Cancer Institute, Fairfax
- VCU Massey Comprehensive Cancer Center, Richmond
被験者募集中観察研究健康なボランティア歓迎
18歳〜90歳 · 全性別 · 2026/07/22更新 · NCT04970056Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
- University of Virginia, Charlottesville
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06937177A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- NEXT Virginia, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT07300150A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- NEXT Virginia, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/29更新 · NCT07458347Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT05005403Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer
- University of Virginia, Charlottesville
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/16更新 · NCT06479239A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/10更新 · NCT06835569Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NEXT Oncology Virginia, Fairfax
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
- NEXT Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/28更新 · NCT07223047Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- Inova Schar Cancer Institute, Fairfax
- Inova Fair Oaks Hospital, Fairfax
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06998940Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Next Oncology Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985A 2-part Phase 1/2 Open-label Trial on ODM-212
- NEXT Oncology Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/04更新 · NCT07563738A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- NEXT Virginia, Fairfax
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/04/24更新 · NCT06385925A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- University of Virginia, Charlottesville
- Virginia Cancer Specialists, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/22更新 · NCT07020221Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
被験者募集中第3相
18歳以上 · 全性別 · 2026/03/31更新 · NCT06807437A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- Virginia Cancer Specialists, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/03/18更新 · NCT06244771Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
- NEXT Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/18更新 · NCT07030257A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Norfolk
- Ohio State University-Telemedicine, Richmond
- Ohio State University Telemedicine, Roanoke
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT06906562Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- NEXT, Virginia, Fairfax
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT07145255LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- VCU Community Memorial Health Center, South Hill
- Shenandoah Oncology PC, Winchester
被験者募集中観察研究
18歳以上 · 全性別 · 2026/01/09更新 · NCT06073431SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Charlottesville
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。